Accuvest Global Advisors Vertex Pharmaceuticals Inc Transaction History

Accuvest Global Advisors

  • $113 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$314.42 - $351.91 $18,236 - $20,410
-58 Reduced 6.42%
845 $297,000
Q1 2023

May 12, 2023
SELL
$283.23 - $323.1 $255,756 - $291,759
-903 Reduced 50.0%
903 $284,000
Q4 2022

Jan 12, 2023
BUY
$285.76 - $321.48 $516,082 - $580,592
1,806 New
1,806 $0

Others Institutions Holding VRTX

# of Institutions
1,717
Shares Held
226M
Call Options Held
1.19M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Accuvest Global Advisors Portfolio

Follow Accuvest Global Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accuvest Global Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Accuvest Global Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email